Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |